You can find the annual or quarterly income statement of Salarius Pharmaceuticals Ord Shs here for insights into the performance and operational efficiency of Salarius Pharmaceuticals Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Operating expenses

--895.13K

R&D expenses

--61.83K

Depreciation, depletion, and amortization

--1.11K

Operating profit

---895.13K

Net non-operating interest income (expenses)

Non-operating interest income

--21.66K

Income before tax

---873.47K

Income after tax

---873.47K

Net income from continuous operations

---873.47K

Net income attributable to controlling interests

---873.47K

Net income attributable to common shareholders

---873.47K

Basic earnings per share

---1.81

Diluted earnings per share

---1.81

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

